Pharma's Almanac | Cell and Gene Therapy (3)

240 Articles Available

3 10

Curative Therapies

Innovation vs Monetization: The Curative Therapy Conundrum

PAO-06-21-NI-03

Cell and Gene Therapy

Expanding a Comprehensive Platform to Support the Future of Cell and Gene Therapies

PAO-05-21-CL-05

Cell Therapy Manufacturing

Thermo Fisher Scientific and UCSF to Open Cell Therapy cGMP Manufacturing and Collaboration Center

PR-M05-21-017

Cell and Gene Therapy

CAR-T Cell and Gene Therapy Market: Challenges and Opportunities

Cell Therapy Manufacturing

Innovating Cell Therapy Manufacturing

PAO-04-22-R221-09

Cell and Gene Therapy Clinical Trials

Minimizing Patient Burden in Cell and Gene Therapy Trials

PAO-04-21-CL-03

Cell and Gene Therapy Logistics

Building Supply Chain Infrastructure for Cell and Gene Therapies

PAO-04-22-R221-07

Cell and Gene Therapy

Reducing the Risk During Cell and Gene Therapy Development and Manufacturing

PAO-03-21-CL-9

COVID-19 Impacts

Q: Putting aside COVID-19 vaccines and therapeutics, what do you think will be the most significant development in the industry in 2021?

PAO-03-21-NI-01

Acquisition

WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers

PR-M11-20-040

Gene Therapy

Anticipating the Next Decade of Gene Therapy

PAO-11-20-CL-02

M&A

Bayer Acquires AskBio to Broaden Innovation Base in Cell and Gene Therapy

PR-M10-20-15

CRISPR RNPs

CRISPR RNPs and the Future of Cell and Gene Therapy

PAP-Q3-20-CL-002

Cell Therapy

Foundational Research Published in Nature Biotechnology Showcases Auxolytic’s Approach to Developing Nutrient-Based Cell Therapy Control Switches

PR-M07-20-NI-018

Agreement

Hansa Biopharma Announces Exclusive Agreement with Sarepta Therapeutics to Develop Imlifidase as Pre-treatment Ahead of Gene Therapy

PR-M07-20-NI-004

Depth Filtration

Robust Harvest Clarification for Adeno-Associated Viral Vectors via Depth Filtration

PAP-Q2-20-CL-030

Cell and Gene Therapy

One-time Treatment Generates New Neurons, Eliminates Parkinson's Disease in Mice

PR-M06-20-NI-036

Obesity

Gene Therapy in Mice Builds Muscle, Reduces Fat

PR-M06-20-NI-037

Gene Editing

Vertex Announces New Clinical Data for Investigational Gene-Editing Therapy CTX001™ in Severe Hemoglobinopathies

PR-M06-20-NI-017

COVID Vaccine

AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company

PR-M05-20-NI-042

CAR-T Cell Therapy

WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform

PR-M05-20-NI-025

First Cell and Gene Therapy Manufacturing Center Located on a U.S. University Campus Is Named

PR-M05-20-NI-010

Capacity Expansion

MilliporeSigma Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity with $110 Million Facility

PR-M04-20-NI-032

AAV Vector Production

Challenges to Process Validation for Viral Vectors

PAP-Q1-20-CL-002

3 10

Cell and Gene Therapy (3)

240 Articles Available

Can't find what you're looking for? Try our advanced search.

Curative Therapies

Innovation vs Monetization: The Curative Therapy Conundrum

Cell and Gene Therapy

Expanding a Comprehensive Platform to Support the Future of Cell and Gene Therapies

Cell Therapy Manufacturing

Thermo Fisher Scientific and UCSF to Open Cell Therapy cGMP Manufacturing and Collaboration Center

Cell and Gene Therapy

CAR-T Cell and Gene Therapy Market: Challenges and Opportunities

Cell Therapy Manufacturing

Innovating Cell Therapy Manufacturing

Cell and Gene Therapy Clinical Trials

Minimizing Patient Burden in Cell and Gene Therapy Trials

Cell and Gene Therapy Logistics

Building Supply Chain Infrastructure for Cell and Gene Therapies

Cell and Gene Therapy

Reducing the Risk During Cell and Gene Therapy Development and Manufacturing

COVID-19 Impacts

Q: Putting aside COVID-19 vaccines and therapeutics, what do you think will be the most significant development in the industry in 2021?

Acquisition

WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers

Gene Therapy

Anticipating the Next Decade of Gene Therapy

M&A

Bayer Acquires AskBio to Broaden Innovation Base in Cell and Gene Therapy

CRISPR RNPs

CRISPR RNPs and the Future of Cell and Gene Therapy

Cell Therapy

Foundational Research Published in Nature Biotechnology Showcases Auxolytic’s Approach to Developing Nutrient-Based Cell Therapy Control Switches

Agreement

Hansa Biopharma Announces Exclusive Agreement with Sarepta Therapeutics to Develop Imlifidase as Pre-treatment Ahead of Gene Therapy

Depth Filtration

Robust Harvest Clarification for Adeno-Associated Viral Vectors via Depth Filtration

Cell and Gene Therapy

One-time Treatment Generates New Neurons, Eliminates Parkinson's Disease in Mice

Obesity

Gene Therapy in Mice Builds Muscle, Reduces Fat

Gene Editing

Vertex Announces New Clinical Data for Investigational Gene-Editing Therapy CTX001™ in Severe Hemoglobinopathies

COVID Vaccine

AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company

CAR-T Cell Therapy

WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform

First Cell and Gene Therapy Manufacturing Center Located on a U.S. University Campus Is Named

Capacity Expansion

MilliporeSigma Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity with $110 Million Facility

AAV Vector Production

Challenges to Process Validation for Viral Vectors